InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,880.00
(
1.58%
)
Post# of 251706
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 826
Posts 119567
Boards Moderated 14
Alias Born 09/05/2002

DewDiligence

Member Level

Re: None

Tuesday, 11/15/2005 4:21:27 AM

Tuesday, November 15, 2005 4:21:27 AM

Post# of 251706
Allergan makes competing $3.2 bln bid for Inamed

[This is a puzzling move by AGN; many of Inamed’s business lines—including breast implants and the LapBand device for obesity—would seem to be a poor fit for AGN’s focus on ophthalmology and dermatology. Moreover, Inamed’s dermal fillers are second-rate products compared to MRX’s Restylane. Finally, the botulinum toxin that Inamed has licensed from a European company is considered clearly inferior to Botox.

The only rationale for this offer that makes sense to me is quashing the Botox competition before it gets off the ground.]

http://yahoo.reuters.com/financeQuoteCompanyNewsArticle.jhtml?duid=mtfh51631_2005-11-15_08-43-38_wen...

>>
Tue Nov 15, 2005 03:43 AM ET

NEW YORK, Nov 15 (Reuters) - Specialty pharmaceutical company Allergan Inc. ( AGN ) has made a $3.2 billion bid for Inamed Corp. ( IMDC ) in an attempt to break up Medicis Pharmaceutical Co.'s ( MRX ) proposed takeover of Inamed.

Allergan said on Tuesday it offered $84 a share in cash and stock for each Inamed share, a premium of nearly 13 percent based on the shares' value at the end of trading on Monday of $74.44. The company said its offer represents a 16 percent premium to Medicis's bid.

Inamed makes breast implants and other cosmetic products,
<<

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up